Respected Data Science Industry Leader Chris Hurley Joins TrialAssure Advisory Leadership Team to Strengthen Data Strategy and Innovation

CANTON, Mich. (December 2,
2025) – TrialAssure, a leading technology provider advancing clinical trial
transparency, disclosure, and data sharing, announced today that Chris Hurley,
MBA, Americas Director for PHUSE and former Director of Data Science at MMS,
has joined TrialAssure’s Advisory Leadership Team. In this role, Hurley will
provide strategic guidance on the company’s data strategy and help shape the
future of TrialAssure’s technology platforms and analytics capabilities.

Hurley brings more than 35
years of experience across clinical data workflows, SAS programming, and
regulatory submission support. As Director of Data Science at MMS, he led
cross-functional initiatives that bridge programming, statistics, and
automation. His ability to translate technical processes into scalable,
business-ready solutions makes him a strong addition to TrialAssure’s advisory
group as the company continues to expand its footprint in AI-powered pharma and
biotech industry tools.

“Chris has a unique
combination of deep technical experience and an intuitive understanding of how
data can accelerate smarter, faster decision-making across the drug development
lifecycle,” said Prasad M. Koppolu, Chief Operating Officer (COO) at
TrialAssure. “His contributions will help us evolve our platform strategy to
meet the needs of global sponsors, regulators, and patients.”

Hurley entered the
pharmaceutical industry in 1990 at Warner-Lambert/Parke-Davis, which later
became part of Pfizer, and has held leadership roles across both Sponsor and
CRO settings. Recognized throughout the industry for his technical leadership
and collaborative approach, Hurley is known for his mentorship, process
development, and active engagement in global forums.

“I’m excited to join
TrialAssure’s Advisory Leadership Team and contribute to its mission of
building smarter tools for the life sciences industry,” said Hurley. “Data
strategy is critical to innovation in clinical research, and TrialAssure is
leading the charge with anonymization and generative AI technology that makes a
measurable impact.”

TrialAssure continues to
expand its advisory network with respected leaders across regulatory science,
medical writing, AI, and clinical operations. Hurley’s appointment reflects the
company’s ongoing investment in expert-driven growth and innovation.